北京科研团队研发脑疾病给药新方法

Core Insights - A Beijing research team has developed a new method for drug delivery to treat neurological diseases, potentially eliminating traditional oral and intravenous methods [1][2] - The breakthrough involves bypassing the blood-brain barrier, which typically prevents most therapeutic drugs from entering the brain [1] - The new technique utilizes tiny nanoparticles that are injected into the skull, where they are taken up by immune cells and transported directly to the brain's affected areas [1] Group 1 - The research was published in the prestigious journal "Cell" on January 17, highlighting its significance in the field [1] - The method shows promising results in animal experiments for stroke treatment, with significant reductions in brain damage and improved neurological function [1] - The research team includes experts from Beijing Tiantan Hospital and Tsinghua University, indicating a strong collaborative effort [1] Group 2 - Initial exploratory treatments using this technology have been conducted on 20 severe stroke patients, showing positive trends in neurological recovery [2] - This research provides a new, precise drug delivery approach for treating various neurological diseases, including stroke and Alzheimer's disease [2] - The findings suggest a potential shift in treatment paradigms for neurological conditions in the future [2]